Although a possible molecular explanation for the severe clinical outcome during SARS-CoV infections is now available, questions remain about the precise pathogenic mechanisms of HCoV-NL63, which also utilizes ACE2 to infect human respiratory cells [25]. This evidence concerns the gene ACE2 and severe acute respiratory syndrome.